Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.9K Sell
397
-681
-63% -$40K ﹤0.01% 2530
2026
Q1
$41.2K Buy
+1,078
New +$34.1K ﹤0.01% 2357
2025
Q2
Hold
0
3768
2025
Q1
Hold
0
3472
2024
Q4
Hold
0
3479
2022
Q4
Sell
-8
Closed -$1K 4602
2022
Q3
$1K Hold
8
﹤0.01% 4498
2022
Q2
$1K Hold
8
﹤0.01% 4275
2022
Q1
$1K Buy
+8
New +$438 ﹤0.01% 4275

Other funds holding ATEX

IFP Advisors's ATEX Position: Q2 2026 in Review

IFP Advisors reduced its Anterix (ATEX) stake by 63% in Q2 2026, selling an estimated $40K and leaving 397 shares worth $40.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2530.

IFP Advisors first reported a position in ATEX in Q1 2022 and has held it in 5 quarters since. The position peaked at $41.2K in Q1 2026. 171 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • IFP Advisors held 397 shares of Anterix worth $40.9K as of Q2 2026.
  • IFP Advisors sold 681 Anterix shares in Q2 2026, an estimated $40K.
  • Anterix made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2530 holding.
  • IFP Advisors first reported a position in Anterix in Q1 2022 and has held it in 5 quarters since.
  • IFP Advisors's Anterix position peaked at $41.2K in Q1 2026.
  • 171 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.